| Biological Sciences | 2021-2025 | 231 | CN 98 | 99.77 |
| Cancer Research | Lifetime | 596 | CN 46 | 96.00 |
| Molecular Medicine | Lifetime | 477 | CN 57 | 83.16 |
| Molecular Biology | 2021-2025 | 63 | CN 29 | 99.76 |
| Cancer Research | 2021-2025 | 21 | CN 9 | 99.28 |
| Oncology | 2021-2025 | 260 | CN 31 | 97.70 |
| Biomedical Engineering | 2021-2025 | 714 | CN 393 | 95.51 |
| Cancer-related molecular mechanisms research | Lifetime | 116 | CN 45 | 99.40 |
| Curcumin's Biomedical Applications | Lifetime | 11 | CN 1 | 99.33 |
| MicroRNA in disease regulation | Lifetime | 154 | CN 49 | 99.30 |
| Circular RNAs in diseases | Lifetime | 111 | CN 59 | 99.07 |
| Autophagy in Disease and Therapy | Lifetime | 222 | CN 26 | 98.32 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 217 | CN 13 | 97.77 |
| RNA Interference and Gene Delivery | Lifetime | 856 | CN 167 | 97.93 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 106 | CN 13 | 97.50 |
| Nanoplatforms for cancer theranostics | Lifetime | 924 | CN 610 | 97.09 |
| FOXO transcription factor regulation | Lifetime | 824 | CN 168 | 76.14 |
| Cancer-related molecular mechanisms research | 2021-2025 | 8 | CN 5 | 99.91 |
| MicroRNA in disease regulation | 2021-2025 | 6 | CN 3 | 99.82 |
| Circular RNAs in diseases | 2021-2025 | 11 | CN 7 | 99.58 |
| RNA Interference and Gene Delivery | 2021-2025 | 19 | CN 12 | 99.35 |
| RNA modifications and cancer | 2021-2025 | 123 | CN 82 | 98.65 |
| Autophagy in Disease and Therapy | 2021-2025 | 52 | CN 22 | 97.42 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 179 | CN 153 | 98.70 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 210 | CN 80 | 96.20 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 38 | CN 9 | 92.20 |
| Extracellular vesicles in disease | 2021-2025 | 606 | CN 363 | 92.36 |
| Cancer Cells and Metastasis | 2021-2025 | 492 | CN 102 | 88.94 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 151 | CN 46 | 89.11 |
| Curcumin's Biomedical Applications | 2021-2025 | 113 | CN 16 | 87.87 |
| Cancer-related gene regulation | 2021-2025 | 424 | CN 285 | 86.22 |
| Graphene and Nanomaterials Applications | 2021-2025 | 729 | CN 188 | 88.51 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 430 | CN 42 | 79.91 |
| FOXO transcription factor regulation | 2021-2025 | 148 | CN 46 | 62.43 |
| Glutathione Transferases and Polymorphisms | 2021-2025 | 308 | CN 70 | 52.60 |
| Tannin, Tannase and Anticancer Activities | 2021-2025 | 209 | CN 28 | 50.70 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 564 | CN 50 | 47.87 |
